Bone health probiotic: BioGaia to launch Osfortis in China via cross-border e-commerce BioGaia is launching its bone health probiotic, Osfortis, into China via cross-border e-commerce (CBEC) channel – its first Asian market for the product.
Osfortis contains the proprietary lactic acid bacterium
Limosilactobacillus reuteri ATCC PTA 6475 and vitamin D3 for the maintenance of normal bone health.
This will add on to existing range of products available in China, including its flagship product Protectis baby drops for infant colic, oral health probiotics Prodentis, and Gastrus, a probiotic for gut health.
These products are sold in China via CBEC and medical professionals.
At the moment, Osfortis is also sold in the US and Europe.
BioGaia forms investment arm with the gut microbiome in mind cosmeticsdesign-europe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cosmeticsdesign-europe.com Daily Mail and Mail on Sunday newspapers.